Skip to content
The Policy VaultThe Policy Vault

YonsaMedica

Prostate cancer – metastatic, castration-resistant

Initial criteria

  • Medication is used in combination with methylprednisolone or dexamethasone
  • Medication is concurrently used with a gonadotropin-releasing hormone (GnRH) analog OR patient has had a bilateral orchiectomy

Approval duration

1 year